KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Sales (2016 - 2025)

Historic Return on Sales for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 0.39%.

  • Gilead Sciences' Return on Sales rose 2300.0% to 0.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.02% for FY2024, which is 1900.0% down from last year.
  • Gilead Sciences' Return on Sales amounted to 0.39% in Q3 2025, which was up 2300.0% from 0.28% recorded in Q2 2025.
  • Gilead Sciences' Return on Sales' 5-year high stood at 0.39% during Q3 2025, with a 5-year trough of 0.62% in Q1 2024.
  • Over the past 5 years, Gilead Sciences' median Return on Sales value was 0.22% (recorded in 2022), while the average stood at 0.17%.
  • In the last 5 years, Gilead Sciences' Return on Sales surged by 8900bps in 2021 and then tumbled by -7800bps in 2024.
  • Gilead Sciences' Return on Sales (Quarter) stood at 0.05% in 2021, then surged by 326bps to 0.22% in 2022, then decreased by -10bps to 0.2% in 2023, then grew by 18bps to 0.24% in 2024, then soared by 67bps to 0.39% in 2025.
  • Its last three reported values are 0.39% in Q3 2025, 0.28% for Q2 2025, and 0.2% during Q1 2025.